• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

DarioHealth Launches Digital Diabetes Program on Walmart.com

Share:

December 10, 2019

Highlights on this story:
  • DarioHealth announce it is expanding the retail distribution of its digital diabetes management program through Walmart.com.
  • Through Walmart’s online distribution channel, DarioHealth will offer Walmart consumers MyDario, a complete digital solution to manage diabetes, hypertension, nutrition, and exercise.

Global digital therapeutics innovation provider, DarioHealth Corp. (NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Walmart is the largest retailer in the world and is the second-largest e-commerce retailer in the U.S. In addition is also an innovator in healthcare, piloting several initiatives such as opening its own Walmart Health centers and creating a Home Health Care section on Walmart.com.

The Dario Blood Glucose Monitoring System Overview

The Dario Blood Glucose Monitoring System combines five essential tools to simplify diabetes management: (1) a sleek, all-in-one smart glucose meter, (2) a personal diabetes progress monitor, (3) on-demand data sharing, (4) emergency hypoglycemia alerts with GPS locator, and (5) a carb counting tool.
The Dario digital diabetes app is among the most downloaded and highest rated healthcare apps, with a 4.9/5.0 star rating and over 8,000+ reviews on the Apple store. Its Net Promoter Score (NPS), a measure of willingness of customers to recommend a company’s products or services to others, is +77, considered “world class” and the highest in its category, on a -100 – +100 scale.

“Walmart strives to offer its shoppers health solutions that will help them manage their own health in the most efficient way possible. We are excited to access Walmart’s online distribution channel given the extremely high volume of annual visitors. We will offer Walmart’s consumers MyDario™, our complete digital solution to manage diabetes, hypertension, nutrition and exercise. Our system is affordable and supported by a large body of clinical evidence that we believe demonstrates that Dario significantly and quickly improves the health and wellness of its users. We believe that the positive results seen while using our system reinforces engagement and are part of the reason why users rate Dario as one of the best solutions for managing chronic conditions,” said Olivier Jarry, DarioHealth’s President and Chief Commercial Officer.

Source: HIT Consultant

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • $13.5M for Binah.ai, $35M for Abacus Insights and More Digital Health Fundings$13.5M for Binah.ai, $35M for Abacus Insights and More Digital Health Fundings
  • COVID-19: Glooko Offers Free Remote Care to Medical Clinics and People with DiabetesCOVID-19: Glooko Offers Free Remote Care to Medical Clinics and People with Diabetes
  • Canavation Product Group Acquires Bio Lab NaturalsCanavation Product Group Acquires Bio Lab Naturals
  • Vitrectomy Devices Industry Outlook 2019-2024 – Market Insights, Dynamics, Revenue and ForecastVitrectomy Devices Industry Outlook 2019-2024 – Market Insights, Dynamics, Revenue and Forecast
  • Healthify, Algorex Health & Excellus BCBS Tap into SDoH Analytics to Address Social DisparitiesHealthify, Algorex Health & Excellus BCBS Tap into SDoH Analytics to Address Social Disparities
  • What Will It Take to Improve Recruitment for Clinical Trials?What Will It Take to Improve Recruitment for Clinical Trials?
  • Alcon Strengthens Foothold in Eye Space with $770M Aerie BuyAlcon Strengthens Foothold in Eye Space with $770M Aerie Buy
  • Shanghai Public Health Clinical Center Uses Wearable Sensors to Combat Spread of Coronavirus in ChinaShanghai Public Health Clinical Center Uses Wearable Sensors to Combat Spread of Coronavirus in China

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications